Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Webistes |
     
  4. Contact Us |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce font size Increase font size  
 
 

Our products

Contact us

Sanofi India Limited

Sanofi House,
CTS No.117-B, L&T Business Park,
Saki Vihar Road, Powai,
Mumbai 400072

Tel no. (022) 28032000
Fax no.(022) 28032846

Content :

Pharmaceuticals

Always use our prescription products under medical supervision

 
Pharmaceuticals
Brand nameGeneric nameStrength
AllStar®(Device - insulin pen)
Amaryl® MPMetformin Hydrochloride Sustained Release,Glimepiride and Pioglitazone Hydrochloride Tablets500mg+1mg + 15mg and 500mg+2mg+15mg
Amaryl® MMetformin Hydrochloride Sustained Release and Glimepiride Tablets1mg + 500mg, 2mg + 500mg
Amaryl® M ForteGlimepirideand Metformin Hydrochloride SR Tablets1mg +1000mg, 2mg + 1000mg
Amaryl® MVMetformin Hydrochloride (SR),Glimepiride and Voglibose Tablets500mg+1mg + 0.2mg, 500mg + 2mg + 0.3mg
Apidra®Insulin Glulisine Injection(Monocomponent Insulin Glulisine r-DNA Origin)10ml vial, 3ml cartridges and Solostar pen
Arava®Leflunomide Tablets IP10, 20mg
Augeoz™Cefepime and Tazobactam for Injection1000mg+125mg
Brodactam™Piperacillin(4g) and Tazobactam (0.5g) For Injection USP4g+0.5g
Cardace®Ramipril Tablets IP1.25, 2.5, 5, 10mg
Cardace® ProtectRamipril & Atorvastatin Tablets2.5mg+10mg, 5 mg+10mg
Cardace® AMRamipril and Amlodipine Tablets2.5mg +5mg, 5mg+5mg , 10mg+5mg
Cardace® HRamipril & Hydrochlorothiazide Tablets IP2.5mg+12.5mg, 5mg+12.5mg, 10mg+12.5mg
Cardace® MetoRamipril & Metoprolol Succinate Extended Release Tablets2.5mg+ 23.75mg, 5mg +47.5mg
CaspercidCaspofungin Acetate for Injection (Lyophilized)50mg , 70 mg
Cetapin® PPioglitazone Hydrochloride & Metformin Hydrochloride SR Tablets15mg+500mg
Cetapin® XRMetformin Hydrochloride Prolonged Release Tablets IP500, 1000mg
Cetapin®VMetformin Hydrochloride Sustained Release and Voglibose Tablet0.2, 0.3mg
Clexane®Enoxaparin Sodium Injection I.P.20mg, 40mg, 60mg, 80mg
Daonil®Glibenclamide Tablets IP5mg
Daonil® MGlibenclamide and Metformin Hydrochloride Sustained Release Tablets5mg+500mg
Frisium®Clobazam tablets IP5mg, 10mg, 20mg
Insuman® RapidHuman Insulin Injection IP (Monocomponent Insulin r-DNA Otigin)3ml cartridges
Insuman® Comb 25Human Insulin Injection (Monocomponent Insulin r-DNA Otigin)3ml cartridges
Insuman® Comb 50Human Insulin Injection (Monocomponent Insulin r-DNA Otigin)3ml cartridges
Lantus®Insulin Glargine Injection IP (Monocomponent Insulin Glargine r-DNA Origin)10ml vial, 3ml cartridges and Solostar pen
Lasilactone® 50Frusemide and Spironolactone Tablets20mg+50mg
Lasix®Frusemide Tablets I.P. 40mg40mg
Lasix®Frusemide Injection I.P.10mg/ ml
Metosan™ XRMetoprolol Succinate Prolonged Release Tablets IP25mg, 50mg
M-Nem ™Meropenem Injection IP500mg , 1000 mg
Rejusite™Pregabalin Sustained Release & Methylcobalamin Tablets75mg+1500mcg
Semi-Amaryl® /Amaryl®Glimepiride Tablets IP0.5mg, 1mg, 2mg, 3mg
Semi-Daonil®Glibenclamide Tablets IP2.5mg
Targocid®Teicoplanin200mg, 400mg
Taxotere®Docetaxel Injection I.P.20mg/ 1ml
Taxotere®Docetaxel Injection I.P.80mg/ 4ml
Telsite™Telmisartan Tablets IP20, 40, 80mg
Telsite™ AMTelmisartan & Amlodipine Tablets40mg+5mg
Telsite™ AM HTelmisartan, Amlodipine & Hydrochlorothiazide Tablets40mg+5mg+12.5mg
Telsite™ HTelmisartan & Hydrochlorothiazide Tablets USP40mg+12.5mg, 80mg+12.5mg
Trental®Pentoxifylline Extended Release Tablets USP400mg
Vogsite™ MdVoglibose Mouth Dissolving Tablets0.2mg, 0.3 mg
Zolineg™Colistimethate Sodium Powder for Solution for Injection, Infusion or Inhalation1 MIU, 2MIU

Updated July 10, 2017

Module :

Medical Information / Pharmacovigilance

All consumers or patients are advised to contact their doctor or healthcare professional for advice on medicines or any health matters/medical emergencies.

Pharmacovigilance remains a key activity in the assessment of the therapeutic value of products. Sanofi ensures continuous monitoring and management of the safety profile of all its products through its drug safety data collection worldwide.
For reporting adverse events, please send an email to PV.india@sanofi.com

A key activity of Sanofi is to provide updated medical information in compliance with Indian regulations, on its products, to healthcare professionals.
For medical information, please send your queries to medinfo.india@sanofi.com

You can also call us between 9AM and 5PM on any working day* at 022-28032000. Please select IVRS option 2 for medical information and IVRS option 3 for reporting adverse events.

*Please note that we are closed on Saturday, Sunday and Public Holidays.